# PF-06372865 In Subjects With Chronic Low Back Pain

> **NCT02262754** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 302 (actual)

## Conditions studied

- Chronic Low Back Pain

## Interventions

- **DRUG:** PF-06372865
- **DRUG:** Placebo
- **DRUG:** Naproxen

## Key facts

- **NCT ID:** NCT02262754
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262754, "PF-06372865 In Subjects With Chronic Low Back Pain". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT02262754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*